[1] Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

[2] Ribavirin aerosol for acute bronchiolitis

[3] Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants

[4] Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

[5] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

[6] In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)